Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00734_DB01267_nanopub.RAMcziOfcsflhhIvZnhRsfBKljzH0iZmJD2iOuB7KtTog#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00734_DB01267 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00734_DB01267 label "DDI between Risperidone and Paliperidone - Paliperidone is the active metabolite of risperidone, 9-OH-risperidone. Concomitant therapy may increase the adverse effects of paliperidone due to additive paliperidone exposure. Consider alternate therapy. [drugbank_resource:DB00734_DB01267]" assertion.
- drugbank_resource:DB00734_DB01267 identifier "drugbank_resource:DB00734_DB01267" assertion.
- drugbank_resource:DB00734_DB01267 title "DDI between Risperidone and Paliperidone - Paliperidone is the active metabolite of risperidone, 9-OH-risperidone. Concomitant therapy may increase the adverse effects of paliperidone due to additive paliperidone exposure. Consider alternate therapy." assertion.
- drugbank:DB01267 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00734_DB01267 assertion.
- drugbank:DB00734 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00734_DB01267 assertion.